Risk and severity of SARS-CoV-2 reinfection among patients with multiple sclerosis vs. the general population: a population-based study

Risk and severity of SARS-CoV-2 reinfection among patients with multiple sclerosis vs. the general population: a population-based study

Abstract Background We conducted this study to compare the risk of reinfection between multiple sclerosis (MS) patients and a control group without MS. Method In this retrospective study, data of all SARS-CoV-2 tests (n = 793,301) and almost all MS patients (n = 10,639) in Isfahan province were coll...

Full description

Bibliographic Details
Main Authors: Mahdi Barzegar, Amirreza Manteghinejad, Sara Bagherieh, Setayesh Sindarreh, Omid Mirmosayyeb, Shaghayegh Haghjooy Javanmard, Vahid Shaygannejad, Maryam Nasirian
Format: Article
Language:English
Published: BMC 2022-10-01
Series:BMC Neurology
Subjects:
Multiple sclerosis
COVID-19
SARS-CoV-2
Reinfection
Rituximab
Online Access:https://doi.org/10.1186/s12883-022-02907-8

Internet

https://doi.org/10.1186/s12883-022-02907-8

Similar Items